Guido Ferrari mostly deals with Virology, Immunology, Antibody, Virus and Epitope. His biological study spans a wide range of topics, including AIDS Vaccines and Immunization. He has included themes like Cytotoxic T cell and HIV vaccine in his Immunology study.
His Antibody study integrates concerns from other disciplines, such as Antigen and AIDSVAX. His study in Virus is interdisciplinary in nature, drawing from both Mutation, Adenoviridae and Heterologous. Within one scientific family, he focuses on topics pertaining to ELISPOT under Epitope, and may sometimes address concerns connected to Cellular immunity and MHC class I.
His main research concerns Virology, Immunology, Antibody, Immune system and Antibody-dependent cell-mediated cytotoxicity. His Virology research includes elements of Epitope, Cytotoxic T cell and HIV vaccine. The various areas that he examines in his HIV vaccine study include Regimen and AIDS Vaccines.
All of his Immunology and T cell, CD8, Vaccine efficacy, Antigen and Immunogenicity investigations are sub-components of the entire Immunology study. His Vaccine efficacy study combines topics in areas such as Vaccine trial and AIDSVAX. His Antibody study frequently draws connections between related disciplines such as Effector.
The scientist’s investigation covers issues in Antibody, Virology, Immunology, HIV vaccine and Antibody-dependent cell-mediated cytotoxicity. Guido Ferrari has researched Antibody in several fields, including Effector, Immune system and Vaccination. His research in Virology is mostly focused on Virus.
His Immunology study incorporates themes from HVTN 505, Receptor and Interleukin 15. His HIV vaccine research is multidisciplinary, incorporating elements of Regimen and Immunogenicity. His study looks at the relationship between Antibody-dependent cell-mediated cytotoxicity and fields such as Antigen, as well as how they intersect with chemical problems.
His primary areas of study are Antibody, HIV vaccine, Immunogenicity, Antibody-dependent cell-mediated cytotoxicity and Immunology. His Antibody research is multidisciplinary, incorporating perspectives in Virus, Viral load and Virology. Guido Ferrari specializes in Virology, namely Neutralization.
His work in HIV vaccine tackles topics such as Vaccination which are related to areas like Immune system, Regimen, Reactogenicity and Immunoglobulin G. The study incorporates disciplines such as Epitope, Antigen and Neutralizing antibody in addition to Antibody-dependent cell-mediated cytotoxicity. His studies deal with areas such as Fc receptor, Cytotoxicity and Rhesus macaque as well as Epitope.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke;Michael K.P. Liu;Jesus F. Salazar-Gonzalez;Guido Ferrari.
Journal of Experimental Medicine (2009)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.
Jeffrey R Currier;Ellen G Kuta;Ellen Turk;Lyndsay B Earhart.
Journal of Immunological Methods (2002)
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp.
Science Translational Medicine (2014)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.
Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates.
Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers
Guido Ferrari;Will Humphrey;M. Juliana McElrath;Jean–Louis Excler.
Proceedings of the National Academy of Sciences of the United States of America (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: